文献速递心血管CT

冠状动脉周围脂肪衰减对心血管结局预后价值的系统综述与Meta分析

Prognostic value of pericoronary adipose tissue attenuation in cardiovascular outcomes: a systematic review and meta-analysis.
PubMed 文献 · Eur J Radiol · 2026-08-26

本系统综述与Meta分析纳入21项研究、27个人群共17160例患者,评估冠状动脉周围脂肪组织(PCAT)衰减对心血管结局的预后意义。结果显示PCAT衰减升高与MACE、全因死亡及心源性死亡风险增加显著相关,其中左前降支与右冠状动脉的关联具有统计学意义。测量方法可能影响关联强度,尚需前瞻性验证与标准化。

要点

  • PCAT衰减升高提示冠状动脉炎症,可作为不良心血管事件的影像生物标志物
  • 测量方法不同可能影响PCAT衰减与预后的关联强度,解读时需注意技术差异
  • LAD与RCA的PCAT衰减预后意义较为明确,LCX的关联尚不确定

核心结论

  • PCAT衰减升高与MACE(HR 1.58;95%CI 1.38–1.81,P<0.001)、全因死亡(HR 1.77;95%CI 1.51–2.07,P<0.001)及心源性死亡(HR 2.25;95%CI 1.62–3.13,P<0.001)风险增加显著相关

研究设计与样本

  • 系统综述与Meta分析,遵循PRISMA指南,检索PubMed、Cochrane Library和Web of Science至2025年8月
  • 纳入报告PCAT衰减与心血管结局关联的观察性研究,共21项研究包含27个人群、17160例患者
  • 采用随机效应模型合并风险比,并通过预设亚组与Meta回归分析探索异质性来源

关键影像表现/征象

  • 左前降支与右冠状动脉的PCAT衰减与心血管结局存在显著预后关联,左旋支关联未达统计学意义

诊断标准与关键数值

  • PCAT衰减升高预测MACE的HR为1.58(95%CI 1.38–1.81,P<0.001)
  • PCAT衰减升高预测全因死亡的HR为1.77(95%CI 1.51–2.07,P<0.001)
  • PCAT衰减升高预测心源性死亡的HR为2.25(95%CI 1.62–3.13,P<0.001)
  • Meta回归单因素分析中亚洲人群(P=0.015)、测量方法(Caristo对比其他,P<0.001)和体重指数(P=0.046)为效应修饰因素
  • 多因素分析中仅测量方法保持显著(P=0.021)

临床应用与阅片要点

  • PCAT衰减可作为冠状动脉炎症的非侵入性影像指标,阅片时可关注LAD及RCA周围脂肪密度升高
  • 不同测量方法结果存在差异,报告PCAT衰减时应注明所用软件或算法来源

局限性

  • 存在小样本效应与发表偏倚可能影响关联强度的估计
  • 缺乏对增量预后价值的评价,常规临床应用前需进行前瞻性验证和方法学标准化

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Pericoronary adipose tissue (PCAT) attenuation has emerged as a novel imaging biomarker of coronary inflammation, reflecting dynamic perivascular changes. Elevated PCAT attenuation has been linked to adverse cardiovascular outcomes; however, its prognostic significance across diverse populations, coronary territories, and analytic methods remains unclear. To determine the prognostic value of PCAT attenuation for major adverse cardiovascular events (MACE) and mortality, and to identify potential effect modifiers through subgroup and meta-regression analyses.

METHODS: This systematic review and meta-analysis followed PRISMA guidelines. PubMed, Cochrane Library, and Web of Science were searched through August 2025. Observational studies reporting associations between PCAT attenuation and cardiovascular outcomes were included. Hazard ratios (HRs) were pooled using random-effects models, and prespecified subgroup and meta-regression analyses were conducted to explore heterogeneity.

RESULTS: Twenty-one studies encompassing 27 populations (17,160 patients) were analyzed. Elevated PCAT attenuation was significantly associated with MACE (HR 1.58; 95% CI: 1.38-1.81, p < 0.001), all-cause mortality (HR 1.77; 95% CI: 1.51-2.07, p < 0.001), and cardiac mortality (HR 2.25; 95% CI: 1.62-3.13, p < 0.001). Coronary territory-based analyses showed significant prognostic associations in the left anterior descending and right coronary arteries, whereas the association in the left circumflex artery was not statistically significant. Meta-regression identified Asian population (p = 0.015), measurement method (Caristo vs others; p < 0.001), and body mass index (p = 0.046) as modifiers; only measurement method remained significant (p = 0.021) in multivariable analysis.

CONCLUSION: Higher PCAT attenuation is associated with an increased risk of cardiovascular events, particularly MACE. However, the magnitude of the association may be influenced by measurement methodology, small-study effects, and publication bias. Further prospective validation, methodological standardization, and evaluation of incremental prognostic value are needed before routine clinical implementation.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Isaka, Kato, Horita, et al. Prognostic value of pericoronary adipose tissue attenuation in cardiovascular outcomes: a systematic review and meta-analysis. Eur J Radiol. 2026. PMID: 42659900. doi:10.1016/j.ejrad.2026.113179

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。